InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by JENNIFER COOK. Director active across 1 company, notably BridgeBio Pharma, Inc.. In total, 4 reports have been recorded. History available since 15 June 2026. The latest transaction was filed on 9 July 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is free.
4 of 4 declarations